DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20212492

COVID-19 infected neonate presenting with cytokine storm and sepsis

Mallesh Kariyappa, Sahana Devadas, Aparna Dutt, Varun Govindarajan

Abstract


COVID-19, a clinical syndrome caused by the coronavirus (SARS-CoV-2) became a pandemic following an outbreak of viral pneumonitis, first identified in Wuhan, China. The disease manifestations vary ranging from mild upper respiratory tract infection to severe pneumonitis, acute respiratory distress syndrome (ARDS) and even death. Although most of the neonatal cases are asymptomatic, rarely, they can present with cytokine storm mimicking with similar features of sepsis. This is a case report of SARS-CoV19 positive neonate presenting with sepsis and cytokine storm, 5-day old baby born to SARS-COVID 19 positive mother presented with fever and investigations showed elevated total counts with neutrophilic predominance, thrombocytopenia suggestive of sepsis and increased inflammatory markers suggestive of cytokine storm. Blood culture was sent and baby was started on intravenous antibiotics. In view of cytokine storm intravenous dexamethasone 0.5 mg/kg/day was given intravenously for 5 days. Neonate recovered from illness after 1 week as evidenced clinically and and by the fall in inflammatory markers before discharge. This report opens the possibility of having both sepsis and cytokine storm in a SARS-CoV19 positive neonate.


Keywords


COVID-19, SARS-CoV19, Neonatal sepsis, Cytokine storm

Full Text:

PDF

References


Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, Zhou W. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020;174(7):722-5.

Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol. 2020;37(08):861-5.

Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist needs to know. J Med Virol. 2020;92(6):564-7.

Ragab D, Salah Eldin H, Taeimah M, Khattar R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446.

Shimizu M. Clinical features of cytokine storm syndrome. In: Cron R, Behrens E editors. Cytokine Storm Syndrome. Cham: Springer. 2019;31-42.

Khaertynov S, Boichuk SV, Khaiboullina SF, Anokhin VA, Andreeva AA, Lombardi VC et al. Comparative Assessment of Cytokine Pattern in Early and Late Onset of Neonatal Sepsis. J Immunol res. 2017;8601063:8.

Ng PC. Diagnostic markers of infection in neonates, Archives of Disease in Childhood-Fetal and Neonatal Edition. 2004;89:F229-35.

Martinez MA. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob. Agents Chemother. 2020;64(5):e00399-20.

Recovery Collaborative Group, Horby P, Lim WS. Dexamethasone in hospitalized patients with COVID-19-preliminary report. N Engl J Med. 2020;384(8):693-704.

Wang Y, Jiang W, He Q. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther. 2020;5(1):57.